Manatuck Hill Partners’s Medtronic MDT Stock Holding History

Manatuck Hill Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,000	Closed	-$881K	–	130
2023 Q2	$881K	Buy	+10,000	New	+$861K	0.42%	59

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Manatuck Hill Partners's MDT Position: Q3 2023 in Review

Manatuck Hill Partners sold out of Medtronic (MDT) in Q3 2023, closing a stake of 10,000 shares — an estimated $881K sold.

Manatuck Hill Partners first reported a position in MDT in Q2 2023 and held it in 1 quarter. The position peaked at $881K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Manatuck Hill Partners reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Manatuck Hill Partners sold 10,000 Medtronic shares in Q3 2023, an estimated $881K.
Manatuck Hill Partners first reported a position in Medtronic in Q2 2023 and held it in 1 quarter.
Manatuck Hill Partners's Medtronic position peaked at $881K in Q2 2023.
1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Manatuck Hill Partners's 13F filing for Q3 2023, filed 14 Nov 2023.